Account
11.12.2024
Reflecting on the Pricing and Market Access trends...

In January of this year, we summarized the key trends that our market access experts anticipated wou...

Read more
Insider Insights
17.10.2024
A closer look at Spain’s new pharmaceutical acce...

Spain is set to implement a comprehensive reform to its law of guarantees and rational use of medici...

Read more
Publications
15.10.2024
WODC Europe 2024: Are NICE Achieving Their Timelin...

AUTHORS: Amrit Kaliasethi, Tia Kwong, Mariam Bibi OBJECTIVES  In 2013, England’s National Ins...

Read more
News
03.09.2024
World Orphan Drug Congress Europe 2024

We're thrilled to announce our participation at World Orphan Drug Congress Europe 2024 in Barcelona ...

Read more
News
29.08.2024
ISPOR Europe 2024

We're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...

Read more
Articles
28.08.2024
How to integrate Market Access strategy with evide...

Introduction What is the secret to a successful drug launch? One crucial factor is establishing a cr...

Read more
Insider Insights
28.08.2024
NICE rejects first drug proven to slow Alzheimerâ€...

Despite positive outcomes in treating Alzheimer's disease, NICE cites small benefits and high costs ...

Read more
Insider Insights
15.08.2024
Significant update in US drug pricing: Medicare to...

The Biden administration’s recent drug price negotiations under the Inflation Reduction Act re...

Read more
07.08.2024
What does the right market access organisation str...

Effective pricing and market access (PMA) teams are vital for pharmaceutical companies to secure rei...

Read more
Insider Insights
23.07.2024
Saudi Arabia’s rise: from emerging market to...

The Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.